Skip to main content
Clinical Trials/CTRI/2019/03/018136
CTRI/2019/03/018136Completed未知

Predictive Value of Circulating Free DNA to assess Clinical Outcome in Patients with Oral Cancer

RMLIMS0 sites30 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • 1. Treatment naive cases with early and
  • locally advanced cancer of oral cavity, confirmed by biopsy ( histopathology will be gold standard for diagnosis).
  • 2. Potential candidate for surgery
  • 3. Performance status: ECOG 0-2
  • 4. Patient consent to be part of study.

Exclusion Criteria

  • 1. Patients having a history of any other malignancy from which the patient has been disease-free for less than 2 years, with the exception of adequately treated basal or squamous cell carcinoma of skin.
  • 2. Metastatic cancer of oral cavity.
  • Performance status: ECOG: >=3.
  • Presence of second malignancy.
  • Patients unwilling to take active treatment or to join the study.
  • A serious co-existing medical condition likely to interfere with lab results including a potentially serious infection.

Investigators

Sponsor
RMLIMS

Similar Trials